SPINRAZA DIN 02465663
Health Canada record
| Active ingredient(s) | NUSINERSEN (NUSINERSEN SODIUM) 2.4 MG |
|---|---|
| Dosage form | Solution |
| Route | Intrathecal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M09AX07 NUSINERSEN |
| Original market date | 29-Aug-2017 |
| Current status date | 29-Aug-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Biogen Canada Inc — licence 100797, currently licensed, last inspection rating C (2023-03-21).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19476 | 2017-06-29 | New Drug Submission (NDS) |